The iFlytek-backed post-discharge care management platform received $23m in a round led by Sequoia Capital China.

Hangzhou Jianhai Technology, a China-based healthcare management software provider backed by artificial intelligence technology producer iFlytek, has secured RMB150m ($23m) in series B funding, DealStreetAsia reported yesterday.

Venture capital firm Sequoia Capital China led the round, which included Source Code Capital and Sherpa Healthcare Partners, while Probe Capital was financial adviser for the transaction.

Jinhai Technology has created a software platform that utilises artificial intelligence to help inform care for patients once they have been discharged from hospital.

Sherpa Healthcare…

Robert Lavine

Robert Lavine is special features editor for Global Venturing.